The Justice Department announced in September it would join a whistleblower suit against the health system filed by the hospital’s director of physician services in 2009. The charges that came about as a result of the intervention, filed last week, allege that Halifax’s contracts with three neurosurgeons and seven medical oncologists were improper, in part, because they either paid these physicians more than fair market value, were not commercially reasonable or took into consideration the volume or value of the physicians’ referrals. The suit seeks to recover millions in inappropriate payments as well as damages and penalties, according to the report.
Halifax Health’s General Counsel Dave Davidson denied the allegations.
More Coverage on Halifax Health:
U.S. Intervenes in Suit Against Florida’s Halifax Hospital, Alleges Stark Law Violations
Whistleblower Case Against Florida’s Halifax Health Moves Forward
Halifax Health, Bert Fish to Offer Radiation Again After Merger Fall-Out
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
